| Trial ID: | L0629 |
| Source ID: | NCT06239129
|
| Associated Drug: |
Initiation Of Specific Medications
|
| Title: |
The Stockholm CREAtinine Measurements Project
|
| Acronym: |
SCREAM
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases|Acute Kidney Injury|Diabetes Mellitus|Cardiovascular Diseases|Hypertension
|
| Interventions: |
DRUG: Initiation of specific medications|PROCEDURE: Undertaking of specific procedures|DIAGNOSTIC_TEST: Abnormalities in specific laboratory tests
|
| Outcome Measures: |
Primary: Adverse health events by levels of kidney function, multiple outcomes evaluated such as cardiovascular events, fractures, dementia, cancer, etc, all of them based on claims data and/or laboratory data, 2006-2021|Safety and efficacy of medications by levels of kidney function, multiple outcomes evaluated depending on the treatments of interest, all of them based on claims data and/or laboratory data, 2006-2021|Effect of medications or conditions on kidney function decline, Evaluation of changes in kidney function over time upon occurrence of a certain condition (i.e., heart failure or covid19 infection) or initiation of a specific medication, 2006-2021 | Secondary: Adverse health events associated to laboratory abnormalities, Same as primary objectives but for other laboratory abnormalities different from kidney function measures, 2006-2021
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet | Collaborators: Region Stockholm
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
3200000
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2006-01-01
|
| Completion Date: |
2022-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-02-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06239129
|
